Cholecystography

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Cholecystography
ICD-9-CM 87.59
MeSH D002765

Oral cholecystography is a radiological procedure used to visualize the gallbladder and biliary channels, developed in 1924 by American surgeons Evarts Ambrose Graham and Warren Henry Cole. It is usually indicated in cases of suspected gallbladder disease, and can also be used to determine or rule out the presence of intermittent obstruction of the bile ducts or recurrent biliary disease after biliary surgery.[1]

A radiopaque cholegraphic (contrast) agent, usually iopanoic acid (Telepaque) or its sodium/calcium salt,[2] is orally administered, which is absorbed by the intestine. This excreted material will collect in the gallbladder, where reabsorption of water concentrates the excreted contrast. Since only 10% of gallstones are radiopaque, the remaining 90% will appear as translucent on an opaque background in an abdominal X-ray.

If needed, IV cholecystography and cholangiography may be done.[citation needed]

Current medical practice prefers ultrasound and CT over oral cholecystography.[3]

References[edit]

  1. ^ "Cholecystography". Encyclopædia Britannica. 
  2. ^ "Cholegraphic contrast medium". Medcyclopaedia. GE. 
  3. ^ Duncan, C; Riall, T (2012). "Evidence-Based Current Surgical Practice: Calculous Gallbladder Disease" (PDF). J Gastrointest Surg. 16: 2011–2025. PMC 3496004Freely accessible. PMID 22986769. doi:10.1007/s11605-012-2024-1. Retrieved 29 October 2016.